Shandong Weigao Orthopaedic Device Co., Ltd

XSSC:688161 Stock Report

Market Cap: CN¥11.3b

Shandong Weigao Orthopaedic Device Valuation

Is 688161 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688161 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688161 (CN¥28.42) is trading below our estimate of fair value (CN¥48.05)

Significantly Below Fair Value: 688161 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688161?

Key metric: As 688161 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688161. This is calculated by dividing 688161's market cap by their current earnings.
What is 688161's PE Ratio?
PE Ratio73x
EarningsCN¥154.60m
Market CapCN¥11.29b

Price to Earnings Ratio vs Peers

How does 688161's PE Ratio compare to its peers?

The above table shows the PE ratio for 688161 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.4x
300482 Guangzhou Wondfo BiotechLtd
22.6x27.5%CN¥11.8b
002901 Double Medical Technology
66.9x44.8%CN¥13.5b
688139 Qingdao Haier BiomedicalLtd
29.7x30.1%CN¥10.6b
688575 Shenzhen YHLO Biotech
34.5x38.9%CN¥10.0b
688161 Shandong Weigao Orthopaedic Device
73x30.4%CN¥11.3b

Price-To-Earnings vs Peers: 688161 is expensive based on its Price-To-Earnings Ratio (73x) compared to the peer average (38.4x).

Price to Earnings Ratio vs Industry

How does 688161's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688161 73.0xIndustry Avg. 34.6xNo. of Companies18PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688161 is expensive based on its Price-To-Earnings Ratio (73x) compared to the CN Medical Equipment industry average (34.6x).

Price to Earnings Ratio vs Fair Ratio

What is 688161's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688161 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio73x
Fair PE Ratio33.3x

Price-To-Earnings vs Fair Ratio: 688161 is expensive based on its Price-To-Earnings Ratio (73x) compared to the estimated Fair Price-To-Earnings Ratio (33.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.71

7D

-1.0%

1Y

39.5%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.84

7D

-1.3%

1Y

-14.3%

Chison Medical Technologies

CN¥3.0b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥26.68

7D

2.9%

1Y

-39.1%